The National Institute of Neurological Disorders and Stroke (NINDS) offers this grant, the SBIR Phase IIB Renewal Award, to support additional funding for clinical trials and clinical research. This opportunity is for small business concerns (SBCs) that have previously received NIH SBIR or STTR Phase II awards. The projects must align with NINDS’s mission, focusing on developing drugs, biologics, devices, diagnostics, or various therapies. This grant aims to accelerate the commercialization of capital-intensive clinical trials by fostering partnerships between awardees and third-party investors or strategic partners. Applicants are required to submit a Commercialization Plan detailing secured or anticipated independent third-party funding, which is expected to equal or exceed the requested NINDS funds during the project period.
Opportunity ID: 334753
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-21-265 |
Funding Opportunity Title: | NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 16, 2021 |
Last Updated Date: | Jul 16, 2021 |
Original Closing Date for Applications: | Apr 05, 2024 |
Current Closing Date for Applications: | Apr 05, 2024 |
Archive Date: | May 11, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | (Reissue of PAR-18-665) This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support clinical trials for projects that were previously funded by NIH SBIR and STTR Phase II awards. The projects must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS) and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Since conducting the clinical trials needed for commercialization may be capital-intensive, the FOA aims to facilitate the transition of SBIR Phase II projects to the commercialization stage by promoting partnerships between NIH’s SBIR/STTR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all SBIR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will equal or exceed the NINDS funds being requested throughout the SBIR Phase IIB project period. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-265.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 334753 Full Announcement-PAR-21-265 -> PAR-21-265-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268219 | Aug 05, 2021 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270951 | Dec 16, 2021 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278356 | Nov 14, 2022 | Apr 05, 2024 | View |
Package 1
Mandatory forms
334753 RR_SF424_2_0-2.0.pdf
334753 PHS398_CoverPageSupplement_5_0-5.0.pdf
334753 RR_OtherProjectInfo_1_4-1.4.pdf
334753 PerformanceSite_2_0-2.0.pdf
334753 RR_KeyPersonExpanded_2_0-2.0.pdf
334753 RR_Budget_1_4-1.4.pdf
334753 PHS398_ResearchPlan_4_0-4.0.pdf
334753 SBIR_STTR_Information_1_3-1.3.pdf
334753 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334753 RR_SubawardBudget30_1_4-1.4.pdf
334753 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334753 RR_SF424_5_0-5.0.pdf
334753 PHS398_CoverPageSupplement_5_0-5.0.pdf
334753 RR_OtherProjectInfo_1_4-1.4.pdf
334753 PerformanceSite_4_0-4.0.pdf
334753 RR_KeyPersonExpanded_4_0-4.0.pdf
334753 RR_Budget_3_0-3.0.pdf
334753 PHS398_ResearchPlan_4_0-4.0.pdf
334753 SBIR_STTR_Information_3_0-3.0.pdf
334753 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334753 RR_SubawardBudget30_3_0-3.0.pdf
334753 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
334753 RR_SF424_5_0-5.0.pdf
334753 PHS398_CoverPageSupplement_5_0-5.0.pdf
334753 RR_OtherProjectInfo_1_4-1.4.pdf
334753 PerformanceSite_4_0-4.0.pdf
334753 RR_KeyPersonExpanded_4_0-4.0.pdf
334753 RR_Budget_3_0-3.0.pdf
334753 PHS398_ResearchPlan_5_0-5.0.pdf
334753 SBIR_STTR_Information_3_0-3.0.pdf
334753 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334753 RR_SubawardBudget30_3_0-3.0.pdf
334753 PHS_AssignmentRequestForm_3_0-3.0.pdf